Erste Asset Management GmbH Purchases 68,000 Shares of Masimo Corporation $MASI

Erste Asset Management GmbH increased its position in shares of Masimo Corporation (NASDAQ:MASI) by 73.9% during the third quarter, Holdings Channel reports. The institutional investor owned 160,000 shares of the medical equipment provider’s stock after purchasing an additional 68,000 shares during the period. Erste Asset Management GmbH’s holdings in Masimo were worth $22,870,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after acquiring an additional 66 shares in the last quarter. Assetmark Inc. increased its stake in Masimo by 5.0% during the 2nd quarter. Assetmark Inc. now owns 1,539 shares of the medical equipment provider’s stock valued at $259,000 after purchasing an additional 73 shares in the last quarter. Clearstead Advisors LLC increased its stake in Masimo by 18.4% during the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73 shares in the last quarter. ProShare Advisors LLC raised its holdings in Masimo by 5.3% during the second quarter. ProShare Advisors LLC now owns 1,995 shares of the medical equipment provider’s stock worth $336,000 after buying an additional 101 shares during the last quarter. Finally, Orion Porfolio Solutions LLC lifted its stake in shares of Masimo by 2.2% in the second quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock valued at $819,000 after buying an additional 104 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on MASI shares. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Bank of America initiated coverage on Masimo in a report on Monday, November 17th. They set a “neutral” rating and a $162.00 price objective for the company. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a report on Thursday, January 22nd. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target for the company. in a report on Tuesday, February 17th. Finally, Wells Fargo & Company cut Masimo from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $190.00 to $180.00 in a research note on Wednesday, February 18th. One research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $181.17.

Masimo Stock Performance

Shares of MASI opened at $175.22 on Friday. The stock has a 50 day moving average of $142.27 and a 200 day moving average of $143.87. The company has a market capitalization of $9.41 billion, a price-to-earnings ratio of -16.62, a PEG ratio of 1.77 and a beta of 1.26. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $194.88. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.